The Cigna Group (CI)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $78.26B
Last updated: Nov 17, 2026 at 11:05 AM ET
The Cigna Group (CI) Financials: Revenue, Profit and Cash Flow
The Cigna Group reported revenue of $274.89B for the fiscal year ended Dec 31, 2025, up 12.5% from the year before. That year, net income was $6.29B with a net margin of 2.3%, operating cash flow was $9.60B and free cash flow was $8.39B. The quarter ended Sep 30, 2026 had revenue of $73.72B and net income of $1.70B.
Revenue and Margins
The operating margin was 3.3% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $39.84B, a compound annual rate of 23.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $274.89B | +12.5% | 9.5% | 3.3% | 2.3% |
| Dec 2024 | $244.41B | +26.2% | 10.6% | 3.9% | 1.5% |
| Dec 2023 | $193.69B | +6.6% | 13.0% | 4.4% | 2.8% |
| Dec 2022 | $181.69B | +4.3% | 12.9% | 4.7% | 3.7% |
| Dec 2021 | $174.13B | +5.8% | 13.2% | 4.6% | 3.1% |
| Dec 2020 | $164.55B | +7.0% | 14.7% | 5.0% | 5.2% |
| Dec 2019 | $153.74B | +216.5% | 16.3% | 5.3% | 3.3% |
| Dec 2018 | $48.57B | +16.4% | 33.6% | 8.6% | 5.4% |
| Dec 2017 | $41.72B | +4.7% | 33.8% | 9.4% | 5.3% |
| Dec 2016 | $39.84B | N/A | 32.7% | 7.8% | 4.6% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 66.4% from the year before. In the quarter ended Sep 2026, net income fell 13.7% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $274.89B | $244.41B | $193.69B | $181.69B | $174.13B | $164.55B | $153.74B | $48.57B | $41.72B | $39.84B |
| Cost of revenue | $248.97B | $221.16B | $170.09B | $157.02B | $151.12B | $136.19B | $128.49B | $32.32B | $27.72B | $26.81B |
| Gross profit | $25.99B | $25.96B | $25.18B | $23.50B | $22.95B | $24.21B | $25.08B | $16.33B | $14.09B | $13.03B |
| Operating income | $9.13B | $9.42B | $8.54B | $8.45B | $7.94B | $8.15B | $8.08B | $4.16B | $3.94B | $3.09B |
| Net income | $6.29B | $3.78B | $5.37B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | $2.23B | $1.84B |
| EBITDA | $11.96B | $9.48B | $9.99B | $12.56B | $10.92B | $15.11B | $11.90B | $4.77B | $4.42B | $3.59B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $73.72B | $71.61B | $68.76B | $72.30B | $69.81B | $67.23B | $65.54B | $64.01B | $62.69B | $60.48B | $57.24B | $49.60B |
| Gross profit | N/A | N/A | $6.47B | $5.55B | $5.94B | $7.89B | $6.61B | $6.46B | $6.60B | $6.52B | $6.38B | $6.57B |
| Operating income | N/A | N/A | $2.36B | $2.15B | $2.58B | $2.43B | $1.97B | $2.17B | $2.58B | $2.41B | $2.26B | $2.06B |
| Net income | $1.70B | $1.88B | $1.86B | $1.27B | $1.97B | $1.63B | $1.41B | $1.54B | $825.00M | $1.63B | -$212.00M | $1.11B |
Balance Sheet
As of Dec 2025, total debt of $42.12B exceeded cash and equivalents by $34.45B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | $59.36B |
| Current assets | $47.81B | $48.87B | $37.35B | $30.12B | $36.13B | $27.80B | $29.84B | $20.43B | $9.31B | $13.43B |
| Cash and equivalents | $7.68B | $7.55B | $7.82B | $5.92B | $5.08B | $10.18B | $4.62B | $3.85B | $2.97B | $3.19B |
| Total liabilities | $116.05B | $114.64B | $106.41B | $99.13B | $107.70B | $105.06B | $110.39B | $112.15B | $48.00B | $45.58B |
| Short-term debt | $11.25B | $12.33B | $36.66B | $10.77B | $24.51B | $8.85B | $10.60B | $24.82B | $424.00M | $276.00M |
| Long-term debt | $30.87B | $28.94B | $28.16B | $28.10B | $31.13B | $29.55B | $31.89B | $39.52B | $5.20B | $4.76B |
| Shareholder equity | $41.71B | $41.03B | $46.22B | $44.67B | $47.11B | $50.32B | $45.34B | $41.03B | $13.71B | $13.72B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $157.64B | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | $152.76B |
| Total liabilities | $113.92B | $114.17B | $110.82B | $116.05B | $115.91B | $111.22B | $110.24B | $114.64B | $115.34B | $113.92B | $111.77B | $106.41B |
| Cash and equivalents | $6.19B | $6.30B | $7.04B | $7.68B | $6.03B | $4.33B | $8.33B | $7.55B | $5.89B | $6.79B | $8.44B | $7.82B |
| Shareholder equity | $43.38B | $42.62B | $42.21B | $41.71B | $41.80B | $40.21B | $40.23B | $41.03B | $42.09B | $41.33B | $41.18B | $46.22B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 87.4% of operating cash flow. Dividends and share repurchases together came to 62.3% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B | $10.35B | $9.48B | $3.77B | $4.09B | $4.03B |
| Capital expenditures | $1.21B | $1.41B | $1.57B | $1.29B | $1.15B | $1.09B | $1.05B | $528.00M | $471.00M | $461.00M |
| Free cash flow | $8.39B | $8.96B | $10.24B | $7.36B | $6.04B | $9.26B | $8.44B | $3.24B | $3.62B | $3.56B |
| Dividends paid | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15.00M | $15.00M | $24.34B | $0 | $0 |
| Share repurchases | $3.62B | $7.03B | $2.28B | $7.61B | $7.74B | $4.04B | $1.99B | $342.00M | $2.73B | $139.00M |
| Investing cash flow | -$4.41B | -$2.10B | -$5.17B | $3.10B | -$3.61B | $2.98B | -$734.00M | -$26.38B | -$1.70B | -$2.57B |
| Financing cash flow | -$6.42B | -$7.65B | -$4.29B | -$11.24B | -$8.21B | -$8.53B | -$7.19B | $23.52B | -$2.65B | -$225.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.57B | -$421.00M | $1.13B | $6.15B | $3.42B | -$1.89B | $1.92B | $5.21B | $46.00M | $265.00M | $4.84B | $1.47B |
| Capital expenditures | $278.00M | $297.00M | $267.00M | $322.00M | $278.00M | $285.00M | $327.00M | $337.00M | $399.00M | $370.00M | $300.00M | $365.00M |
| Free cash flow | $2.29B | -$718.00M | $864.00M | $5.83B | $3.14B | -$2.17B | $1.59B | $4.88B | -$353.00M | -$105.00M | $4.54B | $1.10B |
Frequently Asked Questions About CI
What is The Cigna Group's annual revenue?
The Cigna Group reported revenue of $274.89B for the fiscal year ended Dec 31, 2025.
How fast is The Cigna Group's revenue growing?
Revenue was up 12.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 14.8%.
Is The Cigna Group profitable?
Yes. The Cigna Group reported net income of $6.29B for the fiscal year ended Dec 31, 2025, with a net margin of 2.3%.
How much free cash flow does CI generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $9.60B minus capital expenditures of $1.21B produced free cash flow of $8.39B.
How much debt does The Cigna Group have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $30.87B, short-term debt of $11.25B and cash and equivalents of $7.68B.
CI pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors